May 8, 2024 04:05PM Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference

Nov 4, 2022 05:15AM RBC Capital Upgrades Karyopharm Therapeutics (KPTI) to Outperform

May 10, 2022 07:00AM Karyopharm to Participate at the 2022 RBC Capital Markets Global Healthcare Conference

Feb 22, 2022 12:40PM Karyopharm Therapeutics (KPTI) Wild Ride Occurring as M&A Speculation Proved Wrong Amid Executive Departure - RBC

Aug 5, 2021 04:05PM UPDATE: RBC Capital Downgrades Karyopharm Therapeutics (KPTI) to Sector Perform

Mar 29, 2021 06:29AM Karyopharm Therapeutics (KPTI) Current Valuation Underestimates Xpovio Benefit - RBC Capital

Jun 8, 2020 07:31AM Karyopharm Therapeutics (KPTI) Opportunity Seems Underappreciated Post Physician Checks - RBC Capital

May 12, 2020 07:00AM Karyopharm to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference

Mar 6, 2020 04:05PM Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Mar 4, 2020 05:54AM Karyopharm Therapeutics (KPTI) Prices 6.25M Share Common Offering at $24/Sh

Mar 3, 2020 06:36PM Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock

Mar 2, 2020 01:12PM Karyopharm Therapeutics (KPTI) PT Raised to $37 at RBC Capital

Jul 5, 2019 05:29AM Karyopharm Therapeutics (KPTI) PT Raised to $22 at RBC Capital

May 8, 2019 07:00AM Karyopharm to Participate in Upcoming Investor Conferences

May 8, 2019 07:00AM Karyopharm to Participate in Upcoming Investor Conferences

Mar 15, 2019 09:05AM Karyopharm Therapeutics (KPTI) PDUFA Delay Signals FDA Receptivity - RBC

Mar 1, 2019 06:49AM Karyopharm Therapeutics (KPTI) PT Lowered to $16 at RBC Capital

Feb 27, 2019 06:29AM RBC Still Sees Value for Karyopharm Therapeutics' (KPTI) Selinexor Albeit Delayed, PT To $17

Jan 3, 2019 03:59PM Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC

Dec 3, 2018 09:25AM Pre-Open Movers 12/03: (TSRO) (GBT) (NBEV) Higher; (OCUL) (BLUE) (GSK) Lower (more...)

Nov 26, 2018 06:51AM Buy Karyopharm (KPTI) Into ASH - RBC

Oct 8, 2018 10:58AM RBC Capital Remains Buyers of Karyopharm Therapeutics (KPTI) Following 8% Gain

Aug 7, 2018 02:32PM Karyopharm Therapeutics (KPTI) PT Lowered to $25 at RBC Capital, Remains Positive

May 1, 2018 07:58AM Karyopharm Therapeutics (KPTI) PT Raised to $24 at RBC Capital; 'We Would Be Buyers'

Feb 7, 2018 07:00AM Karyopharm to Participate in Upcoming Investor Conferences

Feb 7, 2018 07:00AM Karyopharm to Participate in Upcoming Investor Conferences

Sep 14, 2017 04:28PM RBC Capital Starts Karyopharm Therapeutics (KPTI) at Outperform

Aug 18, 2016 10:44AM Notable Analyst Rating Changes 8/18: (PCLN) (KMI) (TOO) Upgraded; (TWTR) (HMSY) (MMP) Downgraded

Jun 28, 2016 10:48AM Notable Analyst Rating Changes 6/28: (TRV) (OLN) (RIO) Upgraded; (DISH) (LB) (DD) Downgraded

Jun 26, 2014 09:25AM Pre-Open Stock Movers 6/26: (QLTI) (UNXL) (IRM) Higher; (RDEN) (BBBY) (MLHR) Lower (more...)

Feb 6, 2014 08:30AM Karyopharm Therapeutics to Present at Upcoming Healthcare Conferences in February